Marstacimab, an antitissue factor pathway inhibitor, combined with bypassing agents: effects on thrombin generation and in hemostatically normal rats
2025 · Research and Practice in Thrombosis and Haemostasis · 1 citations
https://doi.org/10.1016/j.rpth.2025.103180